Pegylated interferon–induced immune-mediated hepatitis post–liver transplantation
- 1 May 2006
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Liver Transplantation
- Vol. 12 (5), 827-830
- https://doi.org/10.1002/lt.20706
Abstract
A 55‐year‐old Caucasian male developed a well characterized autoimmune hepatitis after completing treatment with pegylated interferon and ribavirin for recurrent hepatitis C. We hypothesize that pegylated interferon triggered a severe form of immune‐mediated hepatitis.Keywords
This publication has 21 references indexed in Scilit:
- Outcomes of acute rejection after interferon therapy in liver transplant recipientsLiver Transplantation, 2004
- Potential Mechanisms of Interferon-α Induced AutoimmunityAutoimmunity, 2003
- High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon-αAmerican Journal of Hematology, 2003
- Autoimmune hepatitis: Clinical challengesGastroenterology, 2001
- Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy.Archives of Internal Medicine, 1998
- Banff schema for grading liver allograft rejection: An international consensus documentJournal of Hepatology, 1997
- Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomesJournal of Hepatology, 1995
- Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis CGastroenterology, 1995
- Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis CGastroenterology, 1992
- Autoimmune Chronic Hepatitis Exacerbated by Alpha-InterferonAnnals of Internal Medicine, 1992